These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37414523)

  • 21. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, risk factors and surgical technical aspects.
    Nardi P; Pellegrino A; Scafuri A; Bellos K; De Propris S; Polisca P; Chiariello L
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):14-9. PubMed ID: 19829137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative).
    Khawaja MZ; Rajani R; Cook A; Khavandi A; Moynagh A; Chowdhary S; Spence MS; Brown S; Khan SQ; Walker N; Trivedi U; Hutchinson N; De Belder AJ; Moat N; Blackman DJ; Levy RD; Manoharan G; Roberts D; Khogali SS; Crean P; Brecker SJ; Baumbach A; Mullen M; Laborde JC; Hildick-Smith D
    Circulation; 2011 Mar; 123(9):951-60. PubMed ID: 21339482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Need for pacemaker implantation in patients with normal QRS duration immediately after transcatheter aortic valve implantation.
    Schoechlin S; Jalil F; Blum T; Ruile P; Hein M; Nührenberg TG; Arentz T; Neumann FJ
    Europace; 2019 Dec; 21(12):1851-1856. PubMed ID: 31578544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological Study-Guided Permanent Pacemaker Implantation in Patients With Conduction Disturbances Following Transcatheter Aortic Valve Implantation.
    Bourenane H; Galand V; Boulmier D; Leclercq C; Leurent G; Bedossa M; Behar N; Pichard C; Polin B; Tomasi J; Verhoye JP; Sharobeem S; Le Guellec M; Donal E; Pavin D; Martins RP; Le Breton H; Auffret V
    Am J Cardiol; 2021 Jun; 149():78-85. PubMed ID: 33753040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis.
    Jilaihawi H; Chin D; Vasa-Nicotera M; Jeilan M; Spyt T; Ng GA; Bence J; Logtens E; Kovac J
    Am Heart J; 2009 May; 157(5):860-6. PubMed ID: 19376312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse Relationship Between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Hamdan A; Guetta V; Klempfner R; Konen E; Raanani E; Glikson M; Goitein O; Segev A; Barbash I; Fefer P; Spiegelstein D; Goldenberg I; Schwammenthal E
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1218-1228. PubMed ID: 26292585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term pacemaker dependency after transcatheter aortic valve implantation.
    Schernthaner C; Kraus J; Danmayr F; Hammerer M; Schneider J; Hoppe UC; Strohmer B
    Wien Klin Wochenschr; 2016 Mar; 128(5-6):198-203. PubMed ID: 26745972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and Predictors of Permanent Pacemaker Implantation in Patients Who Underwent Transcatheter Aortic Valve Replacement: Observation of a Chinese Population.
    Du F; Zhu Q; Jiang J; Chen H; Liu X; Wang J
    Cardiology; 2020; 145(1):27-34. PubMed ID: 31722361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and predictors of late atrioventricular conduction recovery among patients requiring permanent pacemaker for complete heart block after cardiac surgery.
    Kiehl EL; Makki T; Matar RM; Johnston DR; Rickard JW; Tarakji KG; Kanj M; Wazni OM; Saliba WI; Varma N; Wilkoff BL; Cantillon DJ
    Heart Rhythm; 2017 Dec; 14(12):1786-1792. PubMed ID: 28807663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pacemaker implantation and need for ventricular pacing during follow-up after transcatheter aortic valve implantation.
    Ramazzina C; Knecht S; Jeger R; Kaiser C; Schaer B; Osswald S; Sticherling C; Kühne M
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1592-601. PubMed ID: 25223835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permanent pacemaker implantation following aortic valve replacement: current prevalence and clinical predictors.
    Huynh H; Dalloul G; Ghanbari H; Burke P; David M; Daccarett M; Machado C; David S
    Pacing Clin Electrophysiol; 2009 Dec; 32(12):1520-5. PubMed ID: 19804492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry.
    Ledwoch J; Franke J; Gerckens U; Kuck KH; Linke A; Nickenig G; Krülls-Münch J; Vöhringer M; Hambrecht R; Erbel R; Richardt G; Horack M; Zahn R; Senges J; Sievert H;
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E569-77. PubMed ID: 23475694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, predictors and prognostic value of permanent pacemaker implantation following sutureless valve implantation in low-risk aortic stenosis patients.
    Vilalta V; Cediel G; Mohammadi S; López H; Kalavrouziotis D; Resta H; Dumont E; Voisine P; Philippon F; Escabia C; Borrellas A; Alperi A; Bayes-Genis A; Rodes-Cabau J
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35639725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of permanent pacemaker on mortality after transcatheter aortic valve replacement.
    Engborg J; Riechel-Sarup C; Gerke O; Mickley H; Sandgaard NC; Nissen H; Diederichsen AC
    Scand Cardiovasc J; 2017 Feb; 51(1):40-46. PubMed ID: 27624406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
    Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
    ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of conduction disturbances in patients undergoing transcatheter aortic valve replacement.
    Pavlicek V; Mahfoud F; Bubel K; Fries P; Ewen S; Böhm M; Scheller B; Ukena C
    Clin Res Cardiol; 2023 May; 112(5):677-690. PubMed ID: 36680617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrical Dyssynchrony in Cardiac Amyloidosis: Prevalence, Predictors, Clinical Correlates, and Outcomes.
    Martens P; Hanna M; Valent J; Mullens W; Ives L; Kwon DH; Rickard J; Tang WHW
    J Card Fail; 2022 Dec; 28(12):1664-1672. PubMed ID: 35882259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and predictors of pacemaker implantation at follow-up after reversible high-degree sinus node dysfunction or atrioventricular block.
    Habbout A; Sagnard A; Pommier T; Didier R; Garnier F; Fichot M; Bertaux G; Laurent G; Guenancia C
    Pacing Clin Electrophysiol; 2023 Aug; 46(8):994-1002. PubMed ID: 37319108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Ventricular Pacing Dependency and Pacemaker Implantation Predictors after Transcatheter Aortic Valve Replacement - A 1-Year Follow-Up.
    Pinto RA; Proença T; Carvalho MM; Pestana G; Lebreiro A; Adão L; Macedo F
    Arq Bras Cardiol; 2022 Oct; 119(4):522-530. PubMed ID: 35857943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants and prognostic value of in-hospital infection in patients waiting for permanent pacemaker implantation.
    Barbosa MC; Cirillo W; Piza F; Figueiredo MJO; Silvestre OM; Fernandes-Silva MM; Schreiber R; Oliveira MFRA; Oliveira PPM; Silveira-Filho LM; Petrucci O; Coelho-Filho OR; Matos-Souza JR; Sposito AC; Nadruz W
    Int J Cardiol; 2023 Jan; 370():204-208. PubMed ID: 36288783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.